FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment
October 20, 2026
October 20, 2026
WASHINGTON, Oct. 20 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following news release:
* * *
FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment
*
New treatment may allow some patients to maintain viral control after stopping all hepatitis B therapy
*
The U.S. Food and Drug Administration today approved Hibsago (bepirovirsen) injection, in combination with exist . . .
* * *
FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment
*
New treatment may allow some patients to maintain viral control after stopping all hepatitis B therapy
*
The U.S. Food and Drug Administration today approved Hibsago (bepirovirsen) injection, in combination with exist . . .